^
Association details:
| Biomarker: | LIFR expression |
|---|---|
| Cancer: | Glioblastoma |
| Drug: | daunorubicin (Topoisomerase II inhibitor, DNA intercalator) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy
Excerpt:
The expression of A2B5, CD56, NGFR and Pgp appeared to be associated with chemoresistance whereas CD133, EGFR and LIFR expression was characteristic of chemosensitive tumours...
DOI:
10.1007/s10571-009-9366-6
